Role of the adenosine 3′,5′-cyclic monophosphate (cAMP) in enhancing the efficacy of siRNA-mediated gene silencing in neuroblastoma cells

Oncogene

Volumn 24, Issue 25, 2005, Pages 4149-4154

  Hanson, Amy J ^a   Nahreini, Piruz ^a   Andreatta, Cynthia ^a   Yan, Xiang Dong ^a   Prasad, Kedar N ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Antioxidant Research Institute   (United States)

Author keywords

cAMP; Neuroblastoma; Phosphatidylinositol 3 kinase; siRNA

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; BUTYRIC ACID; COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE C; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE SILENCING; GENETIC TRANSFECTION; MAMMAL CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; TRANSCRIPTION REGULATION;

4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE; CELL LINE, TUMOR; CYCLIC AMP; GENE SILENCING; GENES, REPORTER; HUMANS; NEUROBLASTOMA; PHOSPHODIESTERASE INHIBITORS; RNA, SMALL INTERFERING; TRANSFECTION;

CUCUMBER MOSAIC VIRUS; MAMMALIA;

EID: 21244480916     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208577     Document Type: Article

References (21)

1. Bartel DP. (2004). Cell, 116, 281-297.
2. Castell X, Cheviron N, Barnier JV and Diebler MF. (2003). Neurochem. Res., 28, 557-564.
3. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001). Nature, 411, 494-498.
4. Grewal SI and Moazed D. (2003). Science, 301, 798-802.
5. Hannon GJ. (2002). Nature, 418, 244-251.
6. Hanson AJ, Prasad JE, Nahreini P, Andreatta C, Kumar B, Yan XD and Prasad KN. (2003). J. Neurosci. Res., 74, 148-159.
7. Khaled M, Larribere L, Bille K, Ortonne JP, Ballotti R and Bertolotto C. (2003). Pigment Cell Res., 16, 573.
8. Krichevsky AM and Kosik KS. (2002). Proc. Natl. Acad. Sci. USA, 99, 11926-11929.
9. Lee HT and Kay EP. (2003). Invest. Ophthalmol. Vis. Sci., 44, 3816-3825.
10. Morris KV, Chan SW, Jacobsen SE and Looney DJ. (2004). Science, 305, 1289-1292.
11. Nahreini P, Andreatta C and Prasad KN. (2001a). Cell. Mol. Neurobiol., 21, 509-521.
12. Nahreini P, Hovland AR, Kumar B, Andreatta C, Edwards-Prasad J and Prasad KN. (2001b). Cell. Mol. Neurobiol., 21, 65-79.
13. Pfaffl MW, Horgan GW and Dempfle L. (2002). Nucleic Acids Res., 30, e36.
14. Pickford AS and Cogoni C. (2003). Cell Mol. Life Sci., 60, 871-882.
15. Poser S, Impey S, Xia Z and Storm DR. (2003). J. Neurosci., 23, 4420-4427.
16. Prasad KN. (1980). Life Sci., 27, 1351-1358.
17. Prasad KN. (1991). Biol. Rev. Camb. Philos. Soc., 66, 431-451.
18. Prasad KN and Sinha PK. (1976). In vitro, 12, 125-132.
19. Takei Y, Kadomatsu K. Yuzawa Y, Matsuo S and Muramatsu T. (2004). Cancer Res., 64, 3365-3370.
20. Tijsterman M, Ketting RF and Plasterk RH. (2002). Annu. Rev. Genet., 36, 489-519.
21. Yan XD, Hanson AJ, Nahreini P, Koustas WT, Andreatta C and Prasad KN. (2002). In vitro Cell Dev. Biol. Anim., 38, 529-537.